Infectious bronchitis virus in Australia: a model of coronavirus evolution – a review

Quinteros, José A.; Ignjatovic, Jagoda; Chousalkar, Kapil K.; Noormohammadi, Amir H.; Browning, Glenn F.

doi:10.1080/03079457.2021.1939858

Cited by 5 publications

(3 citation statements)

References 107 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…K069-01 GIII (Li et al, 2010) T07/02 GIV (Li et al, 2010) TC07-2 GVI-1 (Li et al, 2010;Mase et al, 2010;Jang et al, 2018;Ma et al, 2019;Wang et al, 2022) IO636/1 GVII-1 (Ma et al, 2019) Australia N1/62 GI-5 (Cumming, 1963;Valastro et al, 2016) VicS GI-6 N1/88 GIII-1 (Ignjatovic and Galli, 1994;Sapats et al, 1996;Valastro et al, 2016) 23/88 GIII-2 NI/03 GV-1 (Quinteros et al, 2021) categorized as a Georgia 13-like on the basis of the S1 region of the S gene. The entire genome sequence has a sequence identity with that of the strain from Georgia, USA, of 94.03%, and the least similar sequence identity with that of the strain from China is 86.03%.…”

Section: Africamentioning

confidence: 99%

Avian infectious bronchitis virus (AIBV) review by continent

Rafique,

Jabeen,

Pervaiz

et al. 2024

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Infectious bronchitis virus (IBV) is a positive-sense, single-stranded, enveloped RNA virus responsible for substantial economic losses to the poultry industry worldwide by causing a highly contagious respiratory disease. The virus can spread quickly through contact, contaminated equipment, aerosols, and personal-to-person contact. We highlight the prevalence and geographic distribution of all nine genotypes, as well as the relevant symptoms and economic impact, by extensively analyzing the current literature. Moreover, phylogenetic analysis was performed using Molecular Evolutionary Genetics Analysis (MEGA-6), which provided insights into the global molecular diversity and evolution of IBV strains. This review highlights that IBV genotype I (GI) is prevalent worldwide because sporadic cases have been found on many continents. Conversely, GII was identified as a European strain that subsequently dispersed throughout Europe and South America. GIII and GV are predominant in Australia, with very few reports from Asia. GIV, GVIII, and GIX originate from North America. GIV was found to circulate in Asia, and GVII was identified in Europe and China. Geographically, the GVI-1 lineage is thought to be restricted to Asia. This review highlights that IBV still often arises in commercial chicken flocks despite immunization and biosecurity measures because of the ongoing introduction of novel IBV variants and inadequate cross-protection provided by the presently available vaccines. Consequently, IB consistently jeopardizes the ability of the poultry industry to grow and prosper. Identifying these domains will aid in discerning the pathogenicity and prevalence of IBV genotypes, potentially enhancing disease prevention and management tactics.

show abstract

Section: Africamentioning

confidence: 99%

Avian infectious bronchitis virus (AIBV) review by continent

Rafique,

Jabeen,

Pervaiz

et al. 2024

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

show abstract

“…In Australia and New Zealand, the co-epidemic lineages include GI-5 (N1/62) and GI-6 (Vic S), which caused mortalities of 40% to 100% between 1961 and 1976. Since 1988, N18/91 (GⅢ-3) and N1/03 (GⅤ) strains have been predominant in Australia, which mainly cause respiratory disease with lower mortality rates [ 32 , 53 ]. In Europe, the most common strains belong to lineages GI-13 (793B-type) and GI-19 (QX-type), followed by Mass-type (GI-1) strains in UK and Spain, D1466-like (GⅡ-1) and D181-like (GⅡ-2) strains in the Netherlands, and Italy 02 (GI-21) and D274 (GI-12) strains in Spain [ 8 , 26 , 27 , 38 , 39 ].…”

Section: Worldwide Distribution Of Avian Infectious Bronchitis Virusmentioning

confidence: 99%

Key Aspects of Coronavirus Avian Infectious Bronchitis Virus

Zhao

Zhang

2023

Pathogens

View full text Add to dashboard Cite

Infectious bronchitis virus (IBV) is an enveloped and positive-sense single-stranded RNA virus. IBV was the first coronavirus to be discovered and predominantly causes respiratory disease in commercial poultry worldwide. This review summarizes several important aspects of IBV, including epidemiology, genetic diversity, antigenic diversity, and multiple system disease caused by IBV as well as vaccination and antiviral strategies. Understanding these areas will provide insight into the mechanism of pathogenicity and immunoprotection of IBV and may improve prevention and control strategies for the disease.

show abstract

“…Recently, GI-28, GI-29, and GVII-I have been identified in China [125,126]. Australia and New Zealand are home to the indigenous lineages GI-5, GI-6, GI-10, GIII-1, and GV-1 [74,127]. The African continent harbors the indigenous GI-26 lineage, observed in Nigeria and Niger [74,128].…”

Section: Emergence and Dissemination Of Ibv Variants Worldwidementioning

confidence: 99%

Global Emergence of Infectious Bronchitis Virus Variants: Evolution, Immunity, and Vaccination Challenges

Abozeid

2023

Transboundary and Emerging Diseases

View full text Add to dashboard Cite

Infectious bronchitis is an acute, extremely contagious viral disease affecting chickens of all ages, leading to devastating economic losses in the poultry industry worldwide. Affected chickens show respiratory distress and/or nephritis, in addition to decrease of egg production and quality in layers. The avian coronavirus, infectious bronchitis virus (IBV), is a rapidly evolving virus due to the high frequency of mutations and recombination events that are common in coronaviruses. This leads to the continual emergence of novel genotypes that show variable or poor crossprotection. The immune response against IBV is complex. Passive, innate and adaptive humoral and cellular immunity play distinct roles in protection against IBV. Despite intensive vaccination using the currently available live-attenuated and inactivated IBV vaccines, IBV continues to circulate, evolve, and trigger outbreaks worldwide, indicating the urgent need to update the current vaccines to control the emerging variants. Different approaches for preparation of IBV vaccines, including DNA, subunit, peptides, virus-like particles, vectored and recombinant vaccines, have been tested in many studies to combat the disease. This review focuses on several key aspects related to IBV, including its clinical significance, the functional structure of the virus, the factors that contribute to its evolution and diversity, the types of immune responses against IBV, and the characteristics of both current and emerging IBV vaccines. The goal is to provide a comprehensive understanding of IBV and explore the emergence of variants, their dissemination around the world, and the challenges to define the efficient vaccination strategies.

show abstract

Infectious bronchitis virus in Australia: a model of coronavirus evolution – a review

Cited by 5 publications

References 107 publications

Avian infectious bronchitis virus (AIBV) review by continent

Avian infectious bronchitis virus (AIBV) review by continent

Key Aspects of Coronavirus Avian Infectious Bronchitis Virus

Global Emergence of Infectious Bronchitis Virus Variants: Evolution, Immunity, and Vaccination Challenges

Contact Info

Product

Resources

About